Clinical Edge Journal Scan

Mediterranean diet protects against gastric cancer


 

Key clinical point: Mediterranean diet is associated with a lower risk of developing gastric cancer.

Major finding: The Mediterranean dietary pattern, which includes a diet rich in fresh fruits, vegetables, milk, yogurt, lentils, and olive oil, was associated with a significantly lower risk for gastric cancer in the third (adjusted odds ratio [aOR] 0.394; 95% CI 0.211-0.736) and fourth (aOR 0.212; 95% CI 0.107-0.419) quartiles. The Prudent, Unhealthy, and High-fruit diets did not show any association with the risk for gastric cancer.

Study details : A case-control study of 172 patients with incident gastric cancer and 314 controls. Four dietary patterns were identified and analyzed: Mediterranean, Prudent, Unhealthy, and High-fruit dietary patterns.

Disclosures: This study was funded by Hashemite University, Jordan. The authors declared no competing interests.

Source: Tayyem R et al. Mediterranean dietary pattern is associated with lower odds of gastric cancer: A case–control study. Cancer Manag Res. 2022;14:2017-2029 (Jun 17). Doi: 10.2147/CMAR.S360468

Recommended Reading

Cardiovascular disease: The leading cause of noncancer death in CRC
MDedge Hematology and Oncology
Hepatic arterial infusion-chemotherapy with FOLFIRINOX: A feasible treatment option for metastatic CRC
MDedge Hematology and Oncology
Beta adrenergic blockade improves the prognosis of patients with CRC
MDedge Hematology and Oncology
Advanced gastric cancer: Efficacy of anti-PD-1 antibodies plus multikinase inhibitors unaffected by liver metastasis
MDedge Hematology and Oncology
Chemoradiotherapy improves survival in resectable gastric cancer
MDedge Hematology and Oncology
Better survival in patients with MSI-high vs MSS gastric cancer despite worse chemotherapy response
MDedge Hematology and Oncology
Hyperglycemia and low BMI increase the risk for gastric cancer
MDedge Hematology and Oncology
Gastric cancer: Neoadjuvant chemotherapy improves outcomes
MDedge Hematology and Oncology
Cisplatin not inferior to oxaliplatin for systemic treatment of resectable GC
MDedge Hematology and Oncology
Dietary iron protects against gastric cancer
MDedge Hematology and Oncology